Actualmente se trata del mayor estudio de esta clase para evaluar los efectos del tratamiento con psilocibina (un principio activo que se encuentra en las llamadas «setas alucinógenas») para la dep...
Read moreTras validar la bioactividad de dos fármacos antiinflamatorios para impedir la replicación del virus del SARS-CoV-2 y fruto del mismo estudio, la iniciativa Covid Moonshot, confirmó que un tercer f...
Read moreUn asunto candente en la oncología actual es encontrar, entre todos los genes potencialmente implicados en el desarrollo o las propiedades malignas del cáncer, las mejores dianas terapéuticas posib...
Read moreOryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today...
Read more3P Biopharmaceuticals, a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, together with Toleranzia, a Swedi...
Read moreUn proyecto estudia unas formas de parásitos específicas del coronavirus para interferir en la capacidad de replicación del SARS-CoV-2 y promover su eliminación
Read moreIn this interview we speak to José Javier García, Vice President of Data Management and Biostatistics at Pivotal (Madrid, Spain), about his company’s involvement in a large-scale clinical trial te...
Read moreThis month Sifted, the technology magazine of the Financial Times, has contacted various experts in the technology industry and in analyzing data on investments, has concluded that the Spanish entrepr...
Read moreThe virtual gathering, one of the most relevant venues for the biotech industry worldwide, allowed SOM biotech to hold more than 70 meetings with key potential business partners and identify opportuni...
Read moreRainer Rothe, Scientific and Regulatory Affairs Officer at Asphalion, attended the online session “Improving Human Health Through Artificial Intelligence” organised by CataloniaBio & HealthTech in...
Read moreEl estudio, publicado en la revista Nature Communications, liderado por el Netherlands Cancer Institute (NKI), ha contado con la colaboración de investigadores del ICO/IDIBELL y del HUB. Se ha demost...
Read moreThe oversubscribed round was co-led by Ysios Capital and INKEF Capital; Lundbeckfonden Ventures and LSP joined the syndicate. Founding investor, BioGeneration Ventures (BGV) and the regional economic ...
Read more